Clinical trial
A Pilot Study of the Effect of Spironolactone Therapy on Exercise Capacity and Endothelial Dysfunction in Pulmonary Arterial Hypertension
NCT01712620 is registered in ClinicalTrials.gov with National Institutes of Health Clinical Center (CC) as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Pilot Study of the Effect of Spironolactone Therapy on Exercise Capacity and Endothelial Dysfunction in Pulmonary Arterial Hypertension
- Lead sponsor
- National Institutes of Health Clinical Center (CC)
- Phase
- Phase 2
- Overall status
- Recruiting
- Start date
- January 10, 2014
- Completion date
- December 31, 2026
- Enrollment
- 70 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.